Drug Shortage Report for TEVA-CLOBETASOL
Report ID | 147696 |
Drug Identification Number | 01910280 |
Brand name | TEVA-CLOBETASOL |
Common or Proper name | CLOBETASOL 0.05% OINT |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CLOBETASOL PROPIONATE |
Strength(s) | 0.05% |
Dosage form(s) | OINTMENT |
Route of administration | TOPICAL TOPICAL |
Packaging size | 15G |
ATC code | D07AD |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-10-20 |
Estimated end date | 2021-11-30 |
Actual end date | 2021-11-17 |
Shortage status | Resolved |
Updated date | 2021-11-18 |
Company comments | Allocating to 100% of market until end of November. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-11-18 | French | Compare |
v3 | 2021-11-18 | English | Compare |
v2 | 2021-10-21 | French | Compare |
v1 | 2021-10-21 | English | Compare |
Showing 1 to 4 of 4